CHRONIC PERIODONTITIS AND RHEUMATOID ARTHRITIS: INTERRELATIONSHIP OF ETIOPATHOGENESIS
DOI:
https://doi.org/10.54890/1694-8882-2025-1-204Abstract
Summary. In chronic periodontitis, the main etiological factors are microorganisms that are found
in plaque scrapings, where they are organized into a biofilm. Gram-negative periodontopathogens,
such as P. gingivalis, A. actinomycetemcomitans, T. denticola, P. intermedia, and T. forsythensis,
have endotoxins in their cell walls, which can cross-react with antigens of joint cartilage and cause
inflammation in the joint.
Pro-inflammatory cytokines: Interleukin-1β, Interleukin-6, Tumor Necrosis Factor alpha, found in periodontal pockets, play a key role in the pathogenesis of rheumatoid arthritis by inducing cellular infiltration of the synovium and an erosive process. To determine the etiological significance of obligate anaerobes, which play a key role in the development of chronic periodontitis and rheumatoid arthritis, molecular genetic methods, specifically real time PCR with the use of the "parodonto-screen" test system, were employed.
Cytokine content in gingival fluid was examined using an enzyme-linked immunosorbent assay (ELISA) with test systems from Vector-Best. PCR analysis showed that the pathological microbial colonization of the periodontium differs from the normal condition. In group 1, where chronic periodontitis and rheumatoid arthritis are present, the frequency of occurrence of pathogens was: P. gingivalis (78%), A. actinomycetemcomitans (58%), P. intermedia (60%), T. forsythensis (100%), T. denticola (75%), Candida albicans (34%). The levels of pro-inflammatory cytokines in group 1 (with periodontitis and rheumatoid arthritis) were as follows: Interleukin-1β 8.23 pg/ml, Interleukin-6 – 2.7 pg/ml, Tumor Necrosis Factor alpha – 4.43 pg/ml, Interleukin-6 in serum –6 pg/ml; while in group 2 (control group), the levels were: Interleukin-1β – 1.8 pg/ml, Interleukin-6 – 0.71 pg/ml, Tumor Necrosis Factor alpha – 1.1 pg/ml, Interleukin-6 in serum – 3 pg/ml. Detection of periodontopathogens and five types of pro- inflammatory cytokines in gingival fluid using real-time polymerase chain reaction Polymerase Chain Reaction and enzyme-linked immunosorbent assay (ELISA) allows for accurate diagnosis of chronic periodontitis and rheumatoid arthritis, which are etiopathogenetically interconnected.
Keywords:
chronic periodontitis, rheumatoid arthritis, periodontopathogens, cytokines, endotoxinsReferences
1. Гордеев А.В., Галушко Е.А., Савушкина Н.М., Лила А.М. Пародонтит – предшественник ревматоидного артрита? Научно-практическая ревматология. 2018;56(5):613-621.
2. Ланчовска М., Фиркова Е. Ревматоидный артрит и хронический пародонтит – хронические заболевания с общим патогенезом. Научно-практическая ревматология. 2007;1:62-67.
3. Майлен Э.А., Чайковская И.В., Соболева А.А., Лесниченко Д.А., Костецкая Н.И. Уровни отдельных цитокинов в сыворотке крови и ротовой жидкости у женщин в постменопаузе, имеющих хронический генерализованный пародонтит и остеопороз. Актуальные проблемы медицины. 2021;44(1):79-91. https://doi.org/10.18413/2687-0940-2021-44-1-79-91
4. Сашкина Т.И., Рунова Г.С., Абдуллаева А.И., Божедомов А.Ю., Салдусова И.В., Зайченко О.В. и др. Динамика секреторного IgA у больных хроническим генерализованным пародонтитом средней тяжести. Вестник РГМУ. 2019;3:50-53. https://doi.org/10.24075/vrgmu.2019.039
5. Старикова И.В. Триголос Н.Н., Алёшина Н.Ф., Патрушева М.С., Питерская Н.В. Показатели местного иммунитета у больных хроническим пародонтитом на фоне метаболического синдрома. Современные проблемы науки и образования. 2014;6. Режим доступа: https://science-education.ru/ru/article/view?id=15554.
6. Afeltra A. Treatment of rheumatoid arthritis: new therapeutic approaches with biological agents. Curr Drug Targets Immune Endocr Metabol Disord. 2001;1(1):45-65. https://doi.org/10.2174/1568008013341677
7. Acharya AB, Thakur S, Muddapur MV, Kulkarni RD. Tumor necrosis factor-α, interleukin-4 and -6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus. J Indian Soc Periodontol. 2016;20(5):509-513. https://doi.org/ 10.4103/0972-124X.201694
8. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440. https://doi.org/10.1146/annurev.immunol.14.1.397
9. Hakala M, Risteli L, Manelius J, Nieminen P, Risteli J. Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis. 1993;52:866-869. https://doi.org/10.1136/ard.52.12.866
10. Henderson B, Ward JM, Ready D. Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A* periodontopathogen? Periodontol 2000. 2010;54(1):78-105. https://doi.org/10.1111/j.1600-0757.2009.00331.x
11. Sibraa PD, Reinhardt RA, Dyer JK, DuBois LM. Acute-phase protein detection and quantification in gingival crevicular fluid by direct and indirect immunodot. J Clin Periodontol. 1991;18(2):101-106. https://doi.org/10.1111/j.1600-051x.1991. tb01697.x
12. Snyderman R., McCarty AG. Analogous mechanism of tissue destruction in rheumatoid arthritis and periodontal disease. In: Genco RJ, Mergenhagen SE, eds. Host-parasite interaction in periodontal disease. Washington DC: Amer Soc Microbiol; 1982:354-362.
13. Firestein GS, Xu W, Townsend K, Broide D, Alvaro-Gracia J, Glasebrook A, et al. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med. 1988;168(5):1573-1586. https://doi.org/10.1084/jem.168.5.1573
14. Hakala M, Aman S, Luukkainen R, Risteli L, Kauppi M, Nieminen P, et al. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis. 1995;54(11):886-890. https://doi.org/10.1136/ard.54.11.886
15. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998;41(7):1141-1151. doi:10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S
16. Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci. 2019;11(30). https://doi.org/10.1038/s41368-019-0064-z
17. Telles PDS, Hanks CT, Machado MAAM, Nör JE. Lipoteichoic Acid Up-regulates VEGF Expression in Macrophages and Pulp Cells. Journal of Dental Research. 2003;82(6):466-470. doi:10.1177/154405910308200612
18. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809-1820. https://doi.org/10.1016/S0140-6736(05)67728-8
19. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol. 1998;160(1):403-409.
20. Haubek D. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis. APMIS Suppl. 2010;(130):1-53. https://doi.org/10.1111/j.1600 0463.2010.02665.x
21. Suresh Unniaachan A, Krishnavilasom Jayakumari N, Sethuraman S. Association betveen Candida species and periodontal disease: A systematic reviev. Curr Med Mycol. 2020:6(2):63-68. https://doi.org/10.18502/СММ.6.2.3420
Downloads
Published
How to Cite
Issue
Section
